AdaptHealth Corp. (AHCO) director granted 18,999 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lundberg Theodore B. reported acquisition or exercise transactions in this Form 4 filing.

AdaptHealth Corp. director Theodore B. Lundberg received a grant of 18,999 restricted stock units of common stock on June 24, 2026. These units will be settled in common stock upon vesting. After this award, he directly holds a reported total of 892,495 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lundberg Theodore B.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	--

Holdings After Transaction: Common Stock — 892,495 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 18,999 shares Price per share: $0.0000 Shares after transaction: 892,495 shares +2 more

5 metrics

RSUs granted 18,999 shares Restricted stock units granted on June 24, 2026

Price per share $0.0000 Grant price per share for 18,999 RSUs

Shares after transaction 892,495 shares Total direct holdings following the RSU grant

Transaction date June 24, 2026 Date of RSU grant reported on Form 4

Transaction code A Grant, award, or other acquisition of common stock

Key Terms

restricted stock units, grant, award, or other acquisition, Form 4, common stock

4 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

common stock financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/26/2026 - 04:09 PM Accepted by SEC EDGAR 06/26/2026 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lundberg Theodore B.

(Last)

(First)

(Middle)

C/O ADAPTHEALTH CORP.

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN

PENNSYLVANIA

19428

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/24/2026		A		18,999⁽¹⁾	A	$0	892,495	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Theodore B. Lundberg	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did AdaptHealth (AHCO) director Theodore B. Lundberg report?

Director Theodore B. Lundberg reported receiving 18,999 restricted stock units of AdaptHealth common stock. The Form 4 shows this as a grant or award transaction, increasing his direct holdings to a reported total of 892,495 shares following the award.

On what date were the 18,999 restricted stock units granted to the AdaptHealth (AHCO) director?

The 18,999 restricted stock units were granted on June 24, 2026. This grant is recorded as a non-derivative acquisition on the Form 4, categorized as a grant, award, or other acquisition of AdaptHealth common stock.

How will Theodore B. Lundberg’s restricted stock units in AdaptHealth (AHCO) be settled?

The restricted stock units will be settled in AdaptHealth common stock upon vesting. A footnote clarifies that these units represent restricted stock units rather than cash, and they convert into common shares once vesting conditions are satisfied.

What are Theodore B. Lundberg’s AdaptHealth (AHCO) holdings after this Form 4 transaction?

Following the grant of 18,999 restricted stock units, Theodore B. Lundberg is reported to directly hold 892,495 shares of AdaptHealth common stock. This total includes the new award and reflects his direct ownership position after the transaction.

Was there a purchase price for the 18,999 AdaptHealth (AHCO) restricted stock units reported?

The Form 4 lists a price per share of $0.0000 for the 18,999 restricted stock units. This indicates the award was granted as compensation rather than acquired through an open-market cash purchase of AdaptHealth common stock.